EUMEDICA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
EUMEDICA
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€7.2m
2024 · €5.8m+€1.3m
Equity
€26.3m
2024 · €22.0m+€4.3m
Cash
€14.8m
2024 · €8.0m+€6.9m
Balance sheet total
€61.2m
2024 · €52.2m+€9.0m
Largest movements
Assets
- Cash +€6.9m
up €6.9m (+86.1%), from €8.0m to €14.8m
mainly Net result for the year (+€7.2m) and Depreciation (+€2.2m)
- Receivables within one year +€1.9m
up €1.9m (+8.6%), from €22.3m to €24.2m
of which Other amounts receivable: +€1.7m
Equity and liabilities
- Profit (loss) carried forward +€3.0m
up €3.0m (+16.7%), from €17.8m to €20.8m
- Trade debts +€2.2m
up €2.2m (+13.3%), from €16.2m to €18.4m
- Other debts +€2.0m
up €2.0m (+138.5%), from €1.4m to €3.4m
- Reserves +€999,875
up €999,875 (+41.7%), from €2.4m to €3.4m
of which Tax-exempt reserves: +€831,475
- Debts after one year -€919,583
down €919,583 (-11.7%), from €7.9m to €6.9m
Income statement
- Turnover +€2.2m
up €2.2m (+2.8%), from €79.0m to €81.2m
- Other operating income +€1.8m
up €1.8m (+57.7%), from €3.2m to €5.0m
- Staff costs +€1.4m
up €1.4m (+12.0%), from €11.8m to €13.2m
- Services and other goods +€1.3m
up €1.3m (+10.9%), from €12.0m to €13.3m
- Goods and materials -€896,508
down €896,508 (-1.9%), from €48.3m to €47.4m
of which Purchases: -€762,886
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€5.8m
Turnover
+€2.2m
Other operating income
+€1.8m
Goods and materials
+€896,508
Services and other goods
-€1.3m
Staff costs
-€1.4m
Depreciation
+€189,714
Write-downs
-€177,880
Other operating charges
-€3,039
Other operating items
+€10,429
Financial income
-€18,964
Financial charges
-€376,779
Taxes
-€490,740
Deferred taxes and other
-€4,193
Result 2025
€7.2m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€12.5m
Investment
-€2.6m
Financing
-€3.1m
Cash 2024
€8.0m
From operations (derived)
+€12.5m
Net result for the year
+€7.2m
Depreciation
+€2.2m
Stocks and contracts
-€19,757
Receivables within one year
-€1.9m
Deferred charges and accrued income
+€159,074
Provisions
-€228
Trade debts
+€2.2m
Tax, wage and social debts
+€747,448
Other debts
+€2.0m
Accrued charges and deferred income
+€31,779
Investment (derived)
-€2.6m
Investment in fixed assets (net)
-€2.6m
Financing
-€3.1m
Debts after one year
-€919,583
Current portion of long-term debt
+€656,094
Contributions, distributions and other
-€2.8m
Cash 2025
€14.8m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €52,161,332 | €61,177,839 | +€9.0m | +17.3% |
| Fixed assets | 21/28 | €20,785,647 | €21,176,684 | +€391,037 | +1.9% |
| Tangible fixed assets | 22/27 | €20,772,910 | €21,116,511 | +€343,602 | +1.7% |
| Land and buildings | 22 | €17,755,478 | €16,145,271 | -€1.6m | -9.1% |
| Plant, machinery and equipment | 23 | €1,949,070 | €1,798,572 | -€150,498 | -7.7% |
| Furniture and vehicles | 24 | €582,091 | €333,613 | -€248,478 | -42.7% |
| Other tangible fixed assets | 26 | €594 | €338 | -€256 | -43.1% |
| Assets under construction and advance payments | 27 | €485,676 | €2,838,717 | +€2.4m | +484.5% |
| Financial fixed assets | 28 | €12,738 | €60,173 | +€47,435 | +372.4% |
| Affiliated companies | 280/1 | €111 | €111 | = | 0.0% |
| Participating interests | 280 | €111 | €111 | = | 0.0% |
| Other financial fixed assets | 284/8 | €12,627 | €60,062 | +€47,435 | +375.7% |
| Shares | 284 | €37 | €37 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €12,590 | €60,024 | +€47,435 | +376.8% |
| Current assets | 29/58 | €31,375,685 | €40,001,155 | +€8.6m | +27.5% |
| Stocks and contracts in progress | 3 | €365,073 | €384,831 | +€19,757 | +5.4% |
| Stocks | 30/36 | €365,073 | €384,831 | +€19,757 | +5.4% |
| Raw materials and consumables | 30/31 | €211,345 | €130,270 | -€81,074 | -38.4% |
| Goods purchased for resale | 34 | €153,729 | €254,560 | +€100,832 | +65.6% |
| Amounts receivable within one year | 40/41 | €22,259,101 | €24,164,444 | +€1.9m | +8.6% |
| Trade receivables | 40 | €21,309,511 | €21,468,406 | +€158,895 | +0.7% |
| Other amounts receivable | 41 | €949,591 | €2,696,038 | +€1.7m | +183.9% |
| Cash at bank and in hand | 54/58 | €7,964,054 | €14,823,497 | +€6.9m | +86.1% |
| Deferred charges and accrued income | 490/1 | €787,456 | €628,383 | -€159,074 | -20.2% |
| Total equity and liabilities | 10/49 | €52,161,332 | €61,177,839 | +€9.0m | +17.3% |
| Equity | 10/15 | €21,971,832 | €26,313,351 | +€4.3m | +19.8% |
| Contributions | 10/11 | €734,976 | €734,976 | = | 0.0% |
| Capital | 10 | €734,976 | €734,976 | = | 0.0% |
| Issued capital | 100 | €734,976 | €734,976 | = | 0.0% |
| Reserves | 13 | €2,394,946 | €3,394,821 | +€999,875 | +41.7% |
| Non-distributable reserves | 130/1 | €73,498 | €73,498 | = | 0.0% |
| Legal reserve | 130 | €73,498 | €73,498 | = | 0.0% |
| Tax-exempt reserves | 132 | €1,168,275 | €1,999,750 | +€831,475 | +71.2% |
| Distributable reserves | 133 | €1,153,174 | €1,321,574 | +€168,400 | +14.6% |
| Profit (loss) carried forward | 14 | €17,807,583 | €20,777,339 | +€3.0m | +16.7% |
| Investment grants | 15 | €1,034,327 | €1,406,215 | +€371,888 | +36.0% |
| Provisions and deferred taxes | 16 | €102,202 | €101,974 | -€228 | -0.2% |
| Provisions for liabilities and charges | 160/5 | €94,704 | €94,704 | = | 0.0% |
| Other liabilities and charges | 164/5 | €94,704 | €94,704 | = | 0.0% |
| Deferred taxes | 168 | €7,498 | €7,270 | -€228 | -3.0% |
| Amounts payable | 17/49 | €30,087,298 | €34,762,514 | +€4.7m | +15.5% |
| Amounts payable after more than one year | 17 | €7,855,694 | €6,936,111 | -€919,583 | -11.7% |
| Financial debts | 170/4 | €7,855,694 | €6,936,111 | -€919,583 | -11.7% |
| Credit institutions | 173 | €7,855,694 | €6,936,111 | -€919,583 | -11.7% |
| Amounts payable within one year | 42/48 | €21,513,554 | €27,076,574 | +€5.6m | +25.9% |
| Current portion of amounts payable after more than one year | 42 | €919,583 | €1,575,677 | +€656,094 | +71.3% |
| Trade debts | 44 | €16,195,692 | €18,357,652 | +€2.2m | +13.3% |
| Suppliers | 440/4 | €16,195,692 | €18,357,652 | +€2.2m | +13.3% |
| Taxes, remuneration and social security | 45 | €2,956,209 | €3,703,657 | +€747,448 | +25.3% |
| Taxes | 450/3 | €1,017,397 | €1,666,681 | +€649,283 | +63.8% |
| Remuneration and social security | 454/9 | €1,938,812 | €2,036,976 | +€98,164 | +5.1% |
| Other amounts payable | 47/48 | €1,442,070 | €3,439,588 | +€2.0m | +138.5% |
| Accrued charges and deferred income | 492/3 | €718,050 | €749,829 | +€31,779 | +4.4% |
| Operating income | 70/76A | €82,202,577 | €86,208,204 | +€4.0m | +4.9% |
| Turnover | 70 | €78,989,449 | €81,209,185 | +€2.2m | +2.8% |
| Other operating income | 74 | €3,161,090 | €4,985,238 | +€1.8m | +57.7% |
| Non-recurring operating income | 76A | €52,039 | €13,782 | -€38,257 | -73.5% |
| Operating charges | 60/66A | €74,446,818 | €76,219,881 | +€1.8m | +2.4% |
| Goods for resale, raw materials and consumables | 60 | €48,292,343 | €47,395,835 | -€896,508 | -1.9% |
| Purchases | 600/8 | €48,178,479 | €47,415,592 | -€762,886 | -1.6% |
| Change in stocks: decrease (increase) | 609 | €113,864 | -€19,757 | -€133,622 | |
| Services and other goods | 61 | €11,953,661 | €13,261,510 | +€1.3m | +10.9% |
| Remuneration, social security and pensions | 62 | €11,807,595 | €13,226,798 | +€1.4m | +12.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,377,689 | €2,187,975 | -€189,714 | -8.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€187,342 | -€9,462 | +€177,880 | +94.9% |
| Other operating charges | 640/8 | €150,510 | €153,549 | +€3,039 | +2.0% |
| Non-recurring operating charges | 66A | €52,362 | €3,677 | -€48,686 | -93.0% |
| Operating profit (loss) | 9901 | €7,755,760 | €9,988,324 | +€2.2m | +28.8% |
| Financial income | 75/76B | €505,804 | €486,840 | -€18,964 | -3.7% |
| Recurring financial income | 75 | €505,804 | €486,840 | -€18,964 | -3.7% |
| Income from current assets | 751 | €30,464 | €145,458 | +€114,994 | +377.5% |
| Other financial income | 752/9 | €475,340 | €341,382 | -€133,958 | -28.2% |
| Financial charges | 65/66B | €365,114 | €741,893 | +€376,779 | +103.2% |
| Recurring financial charges | 65 | €365,114 | €741,893 | +€376,779 | +103.2% |
| Debt charges | 650 | €87,945 | €119,010 | +€31,066 | +35.3% |
| Other financial charges | 652/9 | €277,170 | €622,883 | +€345,713 | +124.7% |
| Profit (loss) for the period before taxes | 9903 | €7,896,449 | €9,733,270 | +€1.8m | +23.3% |
| Transfer from deferred taxes | 780 | €4,421 | €228 | -€4,193 | -94.8% |
| Income taxes | 67/77 | €2,073,128 | €2,563,868 | +€490,740 | +23.7% |
| Taxes | 670/3 | €2,073,411 | €2,564,022 | +€490,611 | +23.7% |
| Tax adjustments and reversals of tax provisions | 77 | €284 | €155 | -€129 | -45.5% |
| Profit (loss) for the period | 9904 | €5,827,742 | €7,169,631 | +€1.3m | +23.0% |
| Transfer from tax-exempt reserves | 789 | €4,313 | €168,400 | +€164,087 | +3804.7% |
| Transfer to tax-exempt reserves | 689 | €999,875 | €999,875 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €4,832,180 | €6,338,156 | +€1.5m | +31.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.